First Generic Launch has Significant First-Mover Advantage Over Later Generic Drug Entrants

Jul 08 13:07 2019 Print This Article

Generic drugs perform better financially if they get to market first. The advantage is amplified if they get there more than one month ahead of competitors.

The post First Generic Launch has Significant First-Mover Advantage Over Later Generic Drug Entrants appeared first on DrugPatentWatch - Make Better Decisions.The post First Generic Launch has Significant First-Mover Advantage Over Later Generic Drug Entrants appeared first on Biotechblog.

Read More

About Article Author

Biotech Blog

  Categories:

Related Items

Valuation of Pharma Companies: 5 Key Considerations

Valuing pharma companies isn’t the same as valuing non-pharma companies, for several reasons. Traditional business considerations are compounded by patent law and FDA approval processes when evaluating the investment potential of… The post Valuation of Pharma Companies: 5 Key Considerations app ...

Truncated Week Ahead: NIFTY Likely To Remain In A Broad Range; Watching These Levels Continues To Remain Imp

In the week that went by, the Indian equity markets did not make any directional move on any side. The index oscillated back and forth in a defined range and went on to end the week on a flat note. The India Volatility Index – INDIAVIX, also remained flat losing just 0.01 points (-0.05%) during t ...

Truncated Week Ahead: NIFTY Likely To Remain In A Broad Range; Watching These Levels Continues To Remain Important

In the week that went by, the Indian equity markets did not make any directional move on any side. The index oscillated back and forth in a defined range and ultimately ended the week on a flat note. The India Volatility Index (INDIAVIX) also remained flat, losing just 0.01 points (-0.05%) during t ...

Merchandise Trade Balance Slips into a Deficit Position in July

Ottawa, September 4, 2019— “With exports falling and imports rising, Canada's merchandise trade balance slipped into a $1.1 billion deficit position in July.” says Doris Chu, a Senior Economist with the Conference Board of Canada.  “After powering the economy in the second quarter, Canada ...

Week Ahead: NIFTY Has A Treacherous Road Ahead; These Sectors To Relatively Out-Perform As Per RRG

The Indian equity markets struggled throughout the previous week to keep its head above the crucial levels and ended the week with modest gains. On anticipated lines, the week remained very volatile as the markets oscillated in a 385-points range. The week that went by digested the reforms initiate ...

The August Stealth Bull That Has Some Investors Cheering

For most investors, it’s been a tough month as headline induced volatility brought the Indexes to their worse August returns since 2015. While a sense of doom and gloom has dominated the popular financial news, select investors that have looked beyond the headlines have seen dramatic gains for th ...

Tech Talk for Monday August 26th 2019

The Bottom Line The traditional period of summer weakness in world equity markets continued last week with all of the weakness occurring on Friday on growing trade war concerns. Equity markets have a history of entering into a period of increased volatility at this time of year with a downward bias ...

Columbia Care is deeply undervalued: Beacon Securities

US cannabis play Columbia Care (Columbia Care Stock Quote, Chart, News NEO:CCHW) gets a positive review from Beacon Securities analyst Russell Stanley on its announcement of a collaboration with a UK pharmaceutical manufacturer for the import of Columbia’s proprietary BeneCeed CBD tablet. In an u ...

Caisse investing in Mexican pharmaceutical company

The Caisse de dépôt et placement du Québec is investing US$500 million in Laboratorios Sanfer, an independent Mexican pharmaceutical company. The company, which currently maintains a ... ...

Tech Talk for Tuesday August 20th 2019

  StockTwits released yesterday @EquityClock Vertex Pharmaceutical $VRTX, a NASDAQ 100 stock moved above $186.33 setting an intermediate uptrend. Dollarama $DOL.CA, a TSX 60 stock moved above $50.74 extending an intermediate uptrend.   Trader’s Corner   Equity Indices and related ETFs Daily ...